326 related articles for article (PubMed ID: 18600031)
21. Biocompatibility of peritoneal dialysis fluids: long-term exposure of nonuremic rats.
Musi B; Braide M; Carlsson O; Wieslander A; Albrektsson A; Ketteler M; Westenfeld R; Floege J; Rippe B
Perit Dial Int; 2004; 24(1):37-47. PubMed ID: 15104335
[TBL] [Abstract][Full Text] [Related]
22. Curcumin ameliorates peritoneal fibrosis via inhibition of transforming growth factor-activated kinase 1 (TAK1) pathway in a rat model of peritoneal dialysis.
Zhao JL; Zhang T; Shao X; Zhu JJ; Guo MZ
BMC Complement Altern Med; 2019 Oct; 19(1):280. PubMed ID: 31647008
[TBL] [Abstract][Full Text] [Related]
23. Role of the renin-angiotensin system in the pathogenesis of peritoneal fibrosis.
Nakamoto H; Imai H; Fukushima R; Ishida Y; Yamanouchi Y; Suzuki H
Perit Dial Int; 2008 Jun; 28 Suppl 3():S83-7. PubMed ID: 18552271
[TBL] [Abstract][Full Text] [Related]
24. Peritoneal dialysis fluid bioincompatibility and new vessel formation promote leukocyte-endothelium interactions in a chronic rat model for peritoneal dialysis.
Schilte MN; Fabbrini P; Wee PM; Keuning ED; Zareie M; Tangelder GJ; Van Lambalgen AA; Beelen RH; Van Den Born J
Microcirculation; 2010 May; 17(4):271-80. PubMed ID: 20536740
[TBL] [Abstract][Full Text] [Related]
25. By reducing production of vascular endothelial growth factor octreotide improves the peritoneal vascular alterations induced by hypertonic peritoneal dialysis solution.
Günal AI; Celiker H; Akpolat N; Ustündag B; Duman S; Akcicek F
Perit Dial Int; 2002; 22(3):301-6. PubMed ID: 12227386
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of Rho-kinase alleviates peritoneal fibrosis and angiogenesis in a rat model of peritoneal dialysis.
Peng W; Zhou Q; Ao X; Tang R; Xiao Z
Ren Fail; 2013 Aug; 35(7):958-66. PubMed ID: 23859538
[TBL] [Abstract][Full Text] [Related]
27. Preventing peritoneal membrane fibrosis in peritoneal dialysis patients.
Zhou Q; Bajo MA; Del Peso G; Yu X; Selgas R
Kidney Int; 2016 Sep; 90(3):515-24. PubMed ID: 27282936
[TBL] [Abstract][Full Text] [Related]
28. A comparison of the biocompatibility of phosphate-buffered saline and dianeal 3.86% in the rat model of peritoneal dialysis.
Wieczorowska-Tobis K; Polubinska A; Breborowicz A; Oreopoulos DG
Adv Perit Dial; 2001; 17():42-6. PubMed ID: 11510294
[TBL] [Abstract][Full Text] [Related]
29. Inhibiting core fucosylation attenuates glucose-induced peritoneal fibrosis in rats.
Li L; Shen N; Wang N; Wang W; Tang Q; Du X; Carrero JJ; Wang K; Deng Y; Li Z; Lin H; Wu T
Kidney Int; 2018 Jun; 93(6):1384-1396. PubMed ID: 29571940
[TBL] [Abstract][Full Text] [Related]
30. [Effect of TGF-beta1 stimulation on the smad signal transduction pathway of human peritoneal mesothelial cells].
Zhang H; Liu FY; Liu YH
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Apr; 29(2):142-7. PubMed ID: 16145896
[TBL] [Abstract][Full Text] [Related]
31. Effects of inhibition of the polyol pathway during chronic peritoneal exposure to a dialysis solution.
van Westrhenen R; Aten J; Aberra M; Dragt CA; Deira G; Krediet RT
Perit Dial Int; 2005 Feb; 25 Suppl 3():S18-21. PubMed ID: 16048249
[TBL] [Abstract][Full Text] [Related]
32. Acute effects of peritoneal dialysis solutions in the mesenteric microcirculation.
Frajewicki V; Brod V; Kushnir D; Kohan R; Bitterman H
Transl Res; 2009 May; 153(5):249-56. PubMed ID: 19375686
[TBL] [Abstract][Full Text] [Related]
33. Impact of rapamycin on peritoneal fibrosis and transport function.
Xu T; Xie JY; Wang WM; Ren H; Chen N
Blood Purif; 2012; 34(1):48-57. PubMed ID: 22922738
[TBL] [Abstract][Full Text] [Related]
34. Caffeic acid phenethyl ester restores mitochondrial homeostasis against peritoneal fibrosis induced by peritoneal dialysis through the AMPK/SIRT1 pathway.
Lu Y; Gao L; Zhang W; Zeng Y; Hu J; Song K
Ren Fail; 2024 Dec; 46(1):2350235. PubMed ID: 38721924
[TBL] [Abstract][Full Text] [Related]
35. Peritoneal fibrosis and high transport are induced in mildly pre-injured peritoneum by 3,4-dideoxyglucosone-3-ene in mice.
Yokoi H; Kasahara M; Mori K; Kuwabara T; Toda N; Yamada R; Namoto S; Yamamoto T; Seki N; Souma N; Yamaguchi T; Sugawara A; Mukoyama M; Nakao K
Perit Dial Int; 2013; 33(2):143-54. PubMed ID: 23123666
[TBL] [Abstract][Full Text] [Related]
36. Parthenolide alleviates peritoneal fibrosis by inhibiting inflammation via the NF-κB/ TGF-β/Smad signaling axis.
Zhang Y; Feng W; Peng X; Zhu L; Wang Z; Shen H; Chen C; Xiao L; Li S; Zhao Y; Lin M; Huang Y; Long H; Liang J
Lab Invest; 2022 Dec; 102(12):1346-1354. PubMed ID: 36307537
[TBL] [Abstract][Full Text] [Related]
37. The effects of Panax notoginseng saponins on the cytokines and peritoneal function in rats with peritoneal fibrosis.
Hu W; Zhang Y; Sigdel KR
Ren Fail; 2015; 37(9):1507-13. PubMed ID: 26371362
[TBL] [Abstract][Full Text] [Related]
38. Cyclooxygenase-2 and vascular endothelial growth factor expressions are involved in ultrafiltration failure.
Guo J; Xiao J; Gao H; Jin Y; Zhao Z; Jiao W; Liu Z; Zhao Z
J Surg Res; 2014 May; 188(2):527-536.e2. PubMed ID: 24559584
[TBL] [Abstract][Full Text] [Related]
39. Tanshinone IIA attenuates peritoneal fibrosis through inhibition of fibrogenic growth factors expression in peritoneum in a peritoneal dialysis rat model.
Chunming J; Miao Z; Cheng S; Nana T; Wei Z; Dongwei C; Yuan F
Ren Fail; 2011; 33(3):355-62. PubMed ID: 21401363
[TBL] [Abstract][Full Text] [Related]
40. BIOKID: randomized controlled trial comparing bicarbonate and lactate buffer in biocompatible peritoneal dialysis solutions in children [ISRCTN81137991].
Nau B; Schmitt CP; Almeida M; Arbeiter K; Ardissino G; Bonzel KE; Edefonti A; Fischbach M; Haluany K; Misselwitz J; Kemper MJ; Rönnholm K; Wygoda S; Schaefer F;
BMC Nephrol; 2004 Oct; 5():14. PubMed ID: 15485574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
